Tumor antigen
CA 2465639 A1 · Owner: Green Peptide Co. Ltd · Inventors: Shichijo, Shigeki; Itoh, Kyogo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A gene which is recognized by HLA A2 restricted cytotoxic T lymphocytes (CTL) and/or induces CTL is isolated from a human glyoma cell line KNS60 cDNA library and identified. Based on a tumor antigen encoded by the thus obtained gene, a peptide having the epitope of the tumor antigen is found out.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 29, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 29, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 29, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.